Yeast killer systems

被引:228
作者
Magliani, W [1 ]
Conti, S [1 ]
Gerloni, M [1 ]
Bertolotti, D [1 ]
Polonelli, L [1 ]
机构
[1] UNIV PARMA, FAC MED & CHIRURG, IST MICROBIOL, I-43100 PARMA, ITALY
关键词
D O I
10.1128/CMR.10.3.369
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The killer phenomenon in yeasts has been revealed to be a multicentric model for molecular biologists, virologists, phytopathologists, epidemiologists, industrial and medical microbiologists, mycologists, and pharmacologists. The surprisingly widespread occurrence of the killer phenomenon among taxonomically unrelated microorganisms, including prokaryotic and eukaryotic pathogens, has engendered a new interest in its biological significance as well as its theoretical and practical applications. The search for therapeutic opportunities by using yeast killer systems has conceptually opened new avenues for the prevention and control of life-threatening fungal diseases through the idiotypic network that is apparently exploited by the immune system in the course of natural infections. In this review, the biology, ecology, epidemiology, therapeutics, serology, and idiotypy of yeast killer systems are discussed.
引用
收藏
页码:369 / +
页数:1
相关论文
共 462 条
[1]   NETWORK THEORY IN AUTOIMMUNITY - INVITRO SUPPRESSION OF SERUM ANTI-DNA ANTIBODY-BINDING TO DNA BY ANTI-IDIOTYPIC ANTIBODY IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ABDOU, NI ;
WALL, H ;
LINDSLEY, HB ;
HALSEY, JF ;
SUZUKI, T .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (05) :1297-1304
[2]   EPIDEMIOLOGIC TYPING OF NOSOCOMIAL MICROORGANISMS [J].
ABER, RC ;
MACKEL, DC .
AMERICAN JOURNAL OF MEDICINE, 1981, 70 (04) :899-905
[3]   VIRUS-LIKE PARTICLES FROM KILLER, NEUTRAL, AND SENSITIVE STRAINS OF SACCHAROMYCES-CEREVISIAE [J].
ADLER, J ;
WOOD, HA ;
BOZARTH, RF .
JOURNAL OF VIROLOGY, 1976, 17 (02) :472-476
[4]   CHROMOSOMAL MUTANTS OF SACCHAROMYCES-CEREVISIAE AFFECTING CELL-WALL BINDING-SITE FOR KILLER FACTOR [J].
ALAIDROOS, K ;
BUSSEY, H .
CANADIAN JOURNAL OF MICROBIOLOGY, 1978, 24 (03) :228-237
[5]  
ALIOUAT EM, 1993, SERODIAGN IMMUNOTHER, V5, P102
[6]   DEVELOPMENT OF HANSENULA-ANOMALA INFECTION IN A CHILD RECEIVING FLUCONAZOLE THERAPY [J].
ALTER, SJ ;
FARLEY, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (02) :158-159
[7]   BACTERIAL INTERFERENCE AMONG STRAINS OF STAPHYLOCOCCUS-AUREUS IN MAN [J].
ALY, R ;
MAIBACH, HI ;
SHINEFIELD, HR ;
MANDEL, A ;
STRAUSS, WG .
JOURNAL OF INFECTIOUS DISEASES, 1974, 129 (06) :720-724
[8]  
[Anonymous], CLASSIFICATION NOMEN
[9]   NEW KILLER TOXIN OF HANSENULA-MRAKII [J].
ASHIDA, S ;
SHIMAZAKI, T ;
KITANO, K ;
HARA, S .
AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1983, 47 (12) :2953-2955
[10]  
BADGER C C, 1986, Cancer, V58, P584, DOI 10.1002/1097-0142(19860715)58:2+<584::AID-CNCR2820581329>3.0.CO